SCHEMBL4145207

SCHEMBL4145207

C=CCOc1ccc(C(=O)CC(=O)C(C)(C)C)cc1OC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.70
▸ PDE4B Q07343 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.50
▸ CYP2D6 P10635 1/20 0.50
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ POLB P06746 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ ALOX5 P09917 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ STAT3 P40763 1/20 0.44
▸ NFKB2 Q00653 1/20 0.44
▸ RELA Q04206 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4141881 0.87 KDM4E (0.53) KDM4EALDH1A1MEN1KMT2APOLB
SCHEMBL480333 0.85 MAPT (0.57) PDE4BALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL28326914 0.83 KDM4E (1.00) KDM4EPDE4BALDH1A1MEN1KMT2A
SCHEMBL4144753 0.82 KMT2A (0.52) KDM4EALDH1A1MEN1KMT2APOLB
SCHEMBL9306660 0.82 HPGD (0.55) KDM4EPDE4BMEN1KMT2ASMN1; SMN2
SCHEMBL3547607 0.81 KDM4E (0.72) KDM4EPDE4BALDH1A1CYP2D6MEN1
SCHEMBL13773006 0.81 THRA (0.57) KDM4EPDE4BMEN1KMT2ASMN1; SMN2
SCHEMBL14907128 0.80 KDM4E (0.74) KDM4EPDE4BALDH1A1SMN1; SMN2MAPT
SCHEMBL31737057 0.80 KDM4E (0.74) KDM4EPDE4BALDH1A1SMN1; SMN2MAPT
SCHEMBL9305217 0.80 KDM4E (0.74) KDM4EPDE4BALDH1A1CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5371296-A Light stability, sunburn prevention KAO CORPORATION (JP) 1994-12-06 — — US claimed
EP-0504844-A2 4,4-Dimethyl-1-phenylpentane-1,3-dione derivative and UV ray absorbent and cosmetic containing the same KAO CORPORATION (JP) 1992-09-23 — — EP claimed
US-20090169494-A1 Sunscreen cosmetic composition SHISEIDO COMPANY LTD (JP) 2009-07-02 — — US disclosed
EP-1944012-A1 SUNSCREEN COSMETIC COMPOSITION Shiseido Company, Limited (JP) 2008-07-16 — — EP disclosed
EP-0528380-B1 Alkyl-aryl 1,3-propanedion silicone derivative and an external preparation for skin with the derivative compounded therein SHISEIDO CO LTD (JP) 1997-02-26 — — EP disclosed
US-5371296-A Light stability, sunburn prevention KAO CORPORATION (JP) 1994-12-06 — — US disclosed
US-5225583-A Ultraviolet radiation absorbers SHISEIDO CO., LTD. (JP) 1993-07-06 — — US disclosed
US-5191121-A Sunscreen KAO CORPORATION (JP) 1993-03-02 — — US disclosed
EP-0528380-A1 Alkyl-aryl 1,3-propanedion silicone derivative and an external preparation for skin with the derivative compounded therein SHISEIDO COMPANY LIMITED (JP) 1993-02-24 — — EP disclosed
EP-0504844-A2 4,4-Dimethyl-1-phenylpentane-1,3-dione derivative and UV ray absorbent and cosmetic containing the same KAO CORPORATION (JP) 1992-09-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090169494-A1 Sunscreen cosmetic composition SUN2, TYR, AHR KDM4E 1204/4885PDE4B 4235/4885ALDH1A1 395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback